Back
Cardiol Therapeutics 10K Form
Sell
50
CRDL
Cardiol Therapeutics
Last Price:
1.62
Seasonality Move:
35.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CRDL News And Ratings
See the #1 stock for the next 7 days that we like better than CRDL
CRDL Financial Statistics
Sales & Book Value
| Annual Sales: | $62.82K |
|---|---|
| Cash Flow: | $-5.72M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.11 |
| Price / Book: | 17.12 |
Profitability
| EPS (TTM): | -0.39690 |
|---|---|
| Net Income (TTM): | $-26.56M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Cardiol Therapeutics Earnings Forecast
Key Cardiol Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 7 years have been positive in 3 years.
Cardiol Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CRDL |
| Website: | cardiolrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CRDL Technical Analysis vs Fundamental Analysis
Sell
50
Cardiol Therapeutics (CRDL)
is a Sell
Is Cardiol Therapeutics a Buy or a Sell?
-
Cardiol Therapeutics stock is rated a Sell
The current Cardiol Therapeutics [CRDL] share price is $1.62. The Score for CRDL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.